Definium Therapeutics, Inc. Cash Flow Reinvestment Rate
Latest as of June 2019:
0.00x
Definium Therapeutics, Inc. cash flow reinvestment rate. Definium Therapeutics, Inc. (DFTX) has a Cash Flow Reinvestment Rate of 0.00x as of June 2019, reinvesting $0.11 (capex $0.11 ) from operating cash flow of $24.19K. Explore Definium Therapeutics, Inc. debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.11
Capex + Investments
Operating Cash Flow
$24.19K
USD
Capital Expenditures
$0.11
USD
Definium Therapeutics, Inc. Cash Flow Reinvestment Rate by Year (None–None)
Definium Therapeutics, Inc. cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Definium Therapeutics, Inc.. For the full cash flow conversion analysis, see Definium Therapeutics, Inc. (DFTX) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow